Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claire Deback

Showing results (21-30 of 45) with videos related to

Pageof 5
Sort By:
Papillomavirus Research (Amsterdam, Netherlands)|July 9, 2019
Identification by high-throughput sequencing of HPV variants and quasispecies that are untypeable by linear reverse blotting assay in cervical specimensLucie Molet, Delphine Girlich, Rémy A Bonnin, et al.
Journal of Virology|August 8, 2008
Expansion of human cytomegalovirus (HCMV) immediate-early 1-specific CD8+ T cells and control of HCMV replication after allogeneic stem cell transplantationKarim Sacre, Stéphanie Nguyen, Claire Deback, et al.
Microbial Drug Resistance (Larchmont, N.Y.)|October 19, 2016
Mutation in the L3 Ribosomal Protein Could Be Associated with Risk of Selection of High-Level Linezolid-Resistant Staphylococcus epidermidis StrainsCaroline Rouard, Elisabeth Aslangul, Alexandre Rivière, et al.
Antiviral Research|March 20, 2010
Conservation of HHV-6 DNA polymerase processivity factor sequence and predicted structure suggests it as a target for antiviral developmentPascale Bonnafous, Moira Verbelen, Stéphanie Petrella, et al.
Antiviral Therapy|October 9, 2009
Genetic analysis and putative role in resistance to antivirals of the human cytomegalovirus DNA polymerase UL44 processivity factorDavid Boutolleau, Claire Deback, Céline Bressollette-Bodin, et al.
Antiviral Therapy|July 21, 2018
Antiviral effects of Cacicol<sup>®</sup>, a heparan sulfate biomimetic for corneal regeneration therapy, for herpes simplex virus type-1 and varicella zoster virus infectionClaire Deback, Antoine Rousseau, Magali Breckler, et al.
Scientific Reports|May 19, 2022
Initial TK-deficient HSV-1 infection in the lip alters contralateral lip challenge immune dynamicsAntoine Rousseau, Oscar Haigh, Roger Legrand, et al.
Viruses|January 22, 2022
Investigation of Inherited Chromosomally Integrated Human Herpesvirus-6A+ and -6B+ in a Patient with Ulipristal Acetate-Induced Fulminant Hepatic FailureLaure Izquierdo, Clémence M Canivet, Eleonora De Martin, et al.
Journal of Travel Medicine|January 7, 2012
Clinical and microbiological evaluation of travel-associated respiratory tract infections in travelers returning from countries affected by pandemic A(H1N1) 2009 influenzaStéphane Jauréguiberry, David Boutolleau, Eric Grandsire, et al.
Plos Pathogens|December 6, 2016
The CXCL12/CXCR4 Signaling Pathway: A New Susceptibility Factor in Human Papillomavirus PathogenesisFloriane Meuris, Laetitia Carthagena, Agnieszka Jaracz-Ros, et al.
Pageof 5

Showing results (21-30 of 45) with videos related to

Sort By:
Pageof 5
Papillomavirus Research (Amsterdam, Netherlands)|July 9, 2019
Identification by high-throughput sequencing of HPV variants and quasispecies that are untypeable by linear reverse blotting assay in cervical specimensLucie Molet, Delphine Girlich, Rémy A Bonnin, et al.
Journal of Virology|August 8, 2008
Expansion of human cytomegalovirus (HCMV) immediate-early 1-specific CD8+ T cells and control of HCMV replication after allogeneic stem cell transplantationKarim Sacre, Stéphanie Nguyen, Claire Deback, et al.
Microbial Drug Resistance (Larchmont, N.Y.)|October 19, 2016
Mutation in the L3 Ribosomal Protein Could Be Associated with Risk of Selection of High-Level Linezolid-Resistant Staphylococcus epidermidis StrainsCaroline Rouard, Elisabeth Aslangul, Alexandre Rivière, et al.
Antiviral Research|March 20, 2010
Conservation of HHV-6 DNA polymerase processivity factor sequence and predicted structure suggests it as a target for antiviral developmentPascale Bonnafous, Moira Verbelen, Stéphanie Petrella, et al.
Antiviral Therapy|October 9, 2009
Genetic analysis and putative role in resistance to antivirals of the human cytomegalovirus DNA polymerase UL44 processivity factorDavid Boutolleau, Claire Deback, Céline Bressollette-Bodin, et al.
Antiviral Therapy|July 21, 2018
Antiviral effects of Cacicol<sup>®</sup>, a heparan sulfate biomimetic for corneal regeneration therapy, for herpes simplex virus type-1 and varicella zoster virus infectionClaire Deback, Antoine Rousseau, Magali Breckler, et al.
Scientific Reports|May 19, 2022
Initial TK-deficient HSV-1 infection in the lip alters contralateral lip challenge immune dynamicsAntoine Rousseau, Oscar Haigh, Roger Legrand, et al.
Viruses|January 22, 2022
Investigation of Inherited Chromosomally Integrated Human Herpesvirus-6A+ and -6B+ in a Patient with Ulipristal Acetate-Induced Fulminant Hepatic FailureLaure Izquierdo, Clémence M Canivet, Eleonora De Martin, et al.
Journal of Travel Medicine|January 7, 2012
Clinical and microbiological evaluation of travel-associated respiratory tract infections in travelers returning from countries affected by pandemic A(H1N1) 2009 influenzaStéphane Jauréguiberry, David Boutolleau, Eric Grandsire, et al.
Plos Pathogens|December 6, 2016
The CXCL12/CXCR4 Signaling Pathway: A New Susceptibility Factor in Human Papillomavirus PathogenesisFloriane Meuris, Laetitia Carthagena, Agnieszka Jaracz-Ros, et al.
Pageof 5